A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
X-ray Crystallography Core Facility Bookmark and Share

X-ray Crystallography Core Facility

The X-ray Crystallography Core Facility is one of the Shared Resources facilities at Beckman Research Institute of City of Hope.
 
The objective of the facility is to:
 
  1. Provide structural information to understand mechanisms of biological systems at the atomic level;
  2. Validate binding sites of lead compounds of therapeutic interest;
  3. Facilitate lead discovery through co-crystallization of therapeutic targets and small molecule libraries.
     
Services provided include:
 
  • Sample analysis
  • Crystallization
  • Diffraction quality
  • Data collections
  • Structure determination
 
Contact Us:
 
John C. Williams, Ph.D., Director
Phone:  626-256-HOPE (4673), ext. 60227
City of Hope
1500 East Duarte Road
Duarte, CA  91010-3000
Flower Building, Room 148
 
Research reported in this publication included work performed in the X-ray Crystallography Core supported by the National Cancer Institute of the National Institutes of Health under award number P30CA33572. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Services

The X-ray crystallography Core provides a state-of-the-art facility for the generation of crystals and structure determination of macromolecules including proteins, DNA, RNA, and complexes between macromolecules and their ligands.
 
Sample Analysis:
 
Consultation andin silicoanalysis
  • Protein expression and purification
  • Domain structure, including disorder and secondary structure prediction
 
Physical Analysis
 
  • Native PAGE using GE HealthSciences PhastGel
  • Limited Proteolysis and characterization by SDS-PAGE
  • Size Exclusion Chromatography
  • Sedimentation Equilibrium analysis by AUC
  • Sedimentation Velocity analysis by AUC.
 
Crystallization:
 
  1. Set up crystallization trials at 4 ºC and/or 20 ºC.
    a.Initial trials (e.g., appropriate concentrations)
    b.Full scale trials (4 different 96 well factorialsat 3 protein concentrations and 2 temperatures)
     
  2. Optimization – additive screens and factorial overlays
     
  3. Automated Screening at 2 temperatures (scan daily forfirst week, weekly thereafter, finish experiment at 3 months)
 
Diffraction quality:
 
  1. Test diffraction using capillary mounted crystal
     
  2. Test/screen cryo-conditions
 
Data collection:
 
  1. Collect, reduce and merge data. Generate table of statistics
  2. MAD/SAD phasing – help design, collect, reduce and merge MAD data
  3. Generate table of statistics including anomalous dispersion differences
 
Structure Determination:
 
  1. Solve structure by Molecular Replacement
  2. Solve structure by MAD/SAD phasing
  3. Refine structure
  4. Produce relevant statistics (e.g., R and Rfree, RMS deviations)
  5. Structural analysis (superpositions, electrostatics, etc)
  6. Deposit Structure at PDB
 

Equipment

The facility houses a Mosquito Crystallization Robot, a Formulatrix imaging robot (with Automated Crystal Screening at 4 ºC and 20 ºC), a Rigaku Micromax 007 with an R-AxisIV++, and an Oxford cryojet and relevant software and computational hardware for structure determination.
 
The facility also houses a Beckman XLI analytical ultracentrifuge and a GE Health Phast Gel system for the characterization of macromolecular properties.
 
Mosquito Crystallization Robot
The mosquito crystallization robot permits hanging drop, sitting drop, and batch methods in a 96 well format using minimal amounts of protein (~16mL/trail). A number of commercial crystallization screens are available (Qiagen, Hampton Research, Jena).
   
Formulatrix Automated Visualization of Crystallization Trials
The core houses two Formulatrix imaging robots for visualization at 4 ºC and 20 ºC.
Users can quickly browse images, score potential hits and follow crystal growth in time.
   
Rigaku X-ray Diffractometer
Micromax 007 HF, R-axis V++, and Oxford cryojets allow full structure determination.
   
Beckman XL-I Proteomelab
The Beckman Analytical ultracentrifuge affords accurate measurement of hydrodynamic properties, including the association constant of macromolecular complexes, as well as small molecule-macromolecular interactions
 
 

Abstract for Grants

The X-ray core atBeckman Research Institute of City of Hope is a state-of-the-art crystallization and X-ray facility. This facility houses a Mosquito Crystallization robot that uses 50 to 100 nL volumes and permits three different crystallization formats; hanging drop, sitting drops or batch methods under oil. The facility has multiple commercial crystallization factorials (e.g., Hampton, Jena, Nextal), that are frequently used, such that they are always fresh. It has also developed protocols for rapid optimization of individual conditions.
 
To follow crystallization trials, two Formulatrix Imaging Robots are used that automatically image each drop, according to a preset schedule (e.g., nightly). This allows follow-up of crystallization trends at two temperatures and produces a visual record for analysis.
 
For diffraction studies, a Rigaku 007HF generator with an R-axis IV++ imager has been purchased. An Oxford cryojet permits data collection at 100 K to reduce radiation damage.
 
The facility has all the software and computational hardware necessary to determine structures of macromolecular complexes.
 

Pricing

Prices and availability vary. Please contact us for current information.
 
If you are a City of Hope employee, please visit the new intranet site for pricing.

 

 

X-ray Crystallography Core Facility

X-ray Crystallography Core Facility

The X-ray Crystallography Core Facility is one of the Shared Resources facilities at Beckman Research Institute of City of Hope.
 
The objective of the facility is to:
 
  1. Provide structural information to understand mechanisms of biological systems at the atomic level;
  2. Validate binding sites of lead compounds of therapeutic interest;
  3. Facilitate lead discovery through co-crystallization of therapeutic targets and small molecule libraries.
     
Services provided include:
 
  • Sample analysis
  • Crystallization
  • Diffraction quality
  • Data collections
  • Structure determination
 
Contact Us:
 
John C. Williams, Ph.D., Director
Phone:  626-256-HOPE (4673), ext. 60227
City of Hope
1500 East Duarte Road
Duarte, CA  91010-3000
Flower Building, Room 148
 
Research reported in this publication included work performed in the X-ray Crystallography Core supported by the National Cancer Institute of the National Institutes of Health under award number P30CA33572. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Services

Services

The X-ray crystallography Core provides a state-of-the-art facility for the generation of crystals and structure determination of macromolecules including proteins, DNA, RNA, and complexes between macromolecules and their ligands.
 
Sample Analysis:
 
Consultation andin silicoanalysis
  • Protein expression and purification
  • Domain structure, including disorder and secondary structure prediction
 
Physical Analysis
 
  • Native PAGE using GE HealthSciences PhastGel
  • Limited Proteolysis and characterization by SDS-PAGE
  • Size Exclusion Chromatography
  • Sedimentation Equilibrium analysis by AUC
  • Sedimentation Velocity analysis by AUC.
 
Crystallization:
 
  1. Set up crystallization trials at 4 ºC and/or 20 ºC.
    a.Initial trials (e.g., appropriate concentrations)
    b.Full scale trials (4 different 96 well factorialsat 3 protein concentrations and 2 temperatures)
     
  2. Optimization – additive screens and factorial overlays
     
  3. Automated Screening at 2 temperatures (scan daily forfirst week, weekly thereafter, finish experiment at 3 months)
 
Diffraction quality:
 
  1. Test diffraction using capillary mounted crystal
     
  2. Test/screen cryo-conditions
 
Data collection:
 
  1. Collect, reduce and merge data. Generate table of statistics
  2. MAD/SAD phasing – help design, collect, reduce and merge MAD data
  3. Generate table of statistics including anomalous dispersion differences
 
Structure Determination:
 
  1. Solve structure by Molecular Replacement
  2. Solve structure by MAD/SAD phasing
  3. Refine structure
  4. Produce relevant statistics (e.g., R and Rfree, RMS deviations)
  5. Structural analysis (superpositions, electrostatics, etc)
  6. Deposit Structure at PDB
 

Equipment

Equipment

The facility houses a Mosquito Crystallization Robot, a Formulatrix imaging robot (with Automated Crystal Screening at 4 ºC and 20 ºC), a Rigaku Micromax 007 with an R-AxisIV++, and an Oxford cryojet and relevant software and computational hardware for structure determination.
 
The facility also houses a Beckman XLI analytical ultracentrifuge and a GE Health Phast Gel system for the characterization of macromolecular properties.
 
Mosquito Crystallization Robot
The mosquito crystallization robot permits hanging drop, sitting drop, and batch methods in a 96 well format using minimal amounts of protein (~16mL/trail). A number of commercial crystallization screens are available (Qiagen, Hampton Research, Jena).
   
Formulatrix Automated Visualization of Crystallization Trials
The core houses two Formulatrix imaging robots for visualization at 4 ºC and 20 ºC.
Users can quickly browse images, score potential hits and follow crystal growth in time.
   
Rigaku X-ray Diffractometer
Micromax 007 HF, R-axis V++, and Oxford cryojets allow full structure determination.
   
Beckman XL-I Proteomelab
The Beckman Analytical ultracentrifuge affords accurate measurement of hydrodynamic properties, including the association constant of macromolecular complexes, as well as small molecule-macromolecular interactions
 
 

Abstract for Grants

Abstract for Grants

The X-ray core atBeckman Research Institute of City of Hope is a state-of-the-art crystallization and X-ray facility. This facility houses a Mosquito Crystallization robot that uses 50 to 100 nL volumes and permits three different crystallization formats; hanging drop, sitting drops or batch methods under oil. The facility has multiple commercial crystallization factorials (e.g., Hampton, Jena, Nextal), that are frequently used, such that they are always fresh. It has also developed protocols for rapid optimization of individual conditions.
 
To follow crystallization trials, two Formulatrix Imaging Robots are used that automatically image each drop, according to a preset schedule (e.g., nightly). This allows follow-up of crystallization trends at two temperatures and produces a visual record for analysis.
 
For diffraction studies, a Rigaku 007HF generator with an R-axis IV++ imager has been purchased. An Oxford cryojet permits data collection at 100 K to reduce radiation damage.
 
The facility has all the software and computational hardware necessary to determine structures of macromolecular complexes.
 

Pricing

Pricing

Prices and availability vary. Please contact us for current information.
 
If you are a City of Hope employee, please visit the new intranet site for pricing.

 

 
Research Shared Services

City of Hope embodies the spirit of scientific collaboration by sharing services and core facilities with colleagues here and around the world.
 

Recognized nationwide for its innovative biomedical research, City of Hope's Beckman Research Institute is home to some of the most tenacious and creative minds in science.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
Support Our Research
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases.
 
 
 
 
Media Inquiries/Social Media

For media inquiries contact:

Dominique Grignetti
800-888-5323
dgrignetti@coh.org

 

For sponsorships inquiries please contact:

Stefanie Sprester
213-241-7160
ssprester@coh.org

Christine Nassr
213-241-7112
cnassr@coh.org

 
CONNECT WITH US
Facebook  Twitter  YouTube  Blog
 
NEWS & UPDATES
  • Beyond the pink ribbons, special product fundraisers, and the pastel sea of color that marks October, Breast Cancer Awareness Month offers a reason to celebrate and to reflect. More than 2.8 million breast cancer survivors live in the U.S. They are survivors of the second most-common cancer in women, behind ski...
  • Gliomas, a type of tumor that grows in the brain, are very difficult to treat successfully due to their complex nature. That might not always be the case. First some background: The most aggressive and common type of primary brain tumor in adults is glioblastoma. Although the brain tumor mass can often be remov...
  • Cutaneous T cell lymphomas are types of non-Hodgkin lymphoma that arise when infection-fighting white blood cells in the lymphatic system – called lymphocytes – become malignant and affect the skin. The result is rashes and, sometimes, tumors, which can be mistaken for other dermatological conditions. In a smal...
  • Weighing your breast cancer risk? One study suggests a measure to consider is skirt size. A British study suggests that for each increase in skirt size every 10 years after age 25, the five-year risk of developing breast cancer postmenopause increases from one in 61 to one in 51 – a 77 percent increase in risk....
  • Runners prize medals for 5Ks and marathons. Becky Stokes has a medal she cherishes from a very different kind of race: the marathon of treatments necessary to beat her aggressive triple-negative breast cancer. Just a week ago, she completed her last radiation treatment, and danced in the hospital with the staff...
  • Rob Darakjian was diagnosed with acute lymphoblastic leukemia at just 19 years old. He began chemotherapy and was in and out of the hospital for four months. After his fourth round of treatment, he received a bone marrow transplantation from an anonymous donor. Today, he’s cancer free. Darakjian’s s...
  • The environment plays a role in causing cancer – this much we know. But scientists are still trying to understand what that role is, what environmental factors are in play and how precisely those factors are linked to cancer. Now City of Hope researchers have unlocked a clue as to how one carcinogen triggers ca...
  • Jonathan Yamzon, M.D., assistant clinical professor of surgery in the Division of Urology and Urologic Oncology, explains his approach to what’s known as “active surveillance” of men with prostate cancer. Patients need to be educated about their treatment options, he writes. Active surveillanc...
  • For most prostate cancer patients, surgery or radiation therapy is the initial and primary treatment against the disease. But some patients can benefit from chemotherapy and hormone therapy too, especially if there are signs of a relapse or if the cancer has spread beyond the prostate gland. Here, Cy Stein, M.D...
  • Cancer research has yielded scientific breakthroughs that offer patients more options, more hope for survival and a higher quality of life than ever before. The 14.5 million cancer patients living in the United States are living proof that cancer research saves lives. Now, in addition to the clinic, hospital an...
  • Advances in cancer treatment, built on discoveries made in the laboratory then brought to the bedside, have phenomenally changed the reality of living with a cancer diagnosis. More than any other time in history, people diagnosed with cancer are more likely to survive and to enjoy a high quality of life. Howeve...
  • While health care reform has led to an increase in the number of people signing up for health insurance, many people remain uninsured or are not taking full advantage of the health benefits they now have. Still others are finding that, although their premiums are affordable, they aren’t able to see the do...
  • Kidney cancer rates and thyroid cancer rates in adults have continued to rise year after year. Now a new study has found that incidence rates for these cancers are also increasing in children — particularly in African-American children. The study, published online this month in Pediatrics, examined childhood ca...
  • Thyroid cancer has become one of the fastest-growing cancers in the United States for both men and women. The chance of being diagnosed with the cancer has nearly doubled since 1990. This year an estimated 63,000 people will be diagnosed with thyroid cancer in the United States and nearly 1,900 people will die ...
  • Older teenagers and young adults traditionally face worse outcomes than younger children when diagnosed with brain cancer and other central nervous system tumors. A first-of-its-kind study shows why. A team of researchers from the departments of Population Sciences and Pathology at City of Hope recently examine...